Slaoui: COVID-19 Vaccine Trials Will Be Unblinded, But Question Is When

By Beth Wang / November 18, 2020 at 6:09 PM
With news that Pfizer has completed the final analysis of its phase 3 COVID-19 vaccine trial, and Moderna expected to reach its study objectives soon, Operation Warp Speed officials and FDA are having conversations about how and when to move trial participants who are in the placebo arm over to the active vaccine arm, Operation Warp Speed chief Moncef Slaoui said on a Wednesday (Nov. 18) press call. FDA, the vaccine companies and Operation Warp Speed officials are grappling with...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.